Myopia control with contact lenses in children: a systematic review

Authors

  • Catarina Cruz Escola Superior de Tecnologia da Saúde de Lisboa, Instituto Politécnico de Lisboa. Lisboa, Portugal.
  • Cátia Carvalho Escola Superior de Tecnologia da Saúde de Lisboa, Instituto Politécnico de Lisboa. Lisboa, Portugal.
  • Estefanía Almeida Escola Superior de Tecnologia da Saúde de Lisboa, Instituto Politécnico de Lisboa. Lisboa, Portugal.
  • Hugo Farinha Escola Superior de Tecnologia da Saúde de Lisboa, Instituto Politécnico de Lisboa. Lisboa, Portugal.
  • Ilda Maria Poças Escola Superior de Tecnologia da Saúde de Lisboa, Instituto Politécnico de Lisboa. Lisboa, Portugal. CeiED - Centro de Estudos Interdisciplinares em Educação e Desenvolvimento, Universidade Lusófona. Lisboa, Portugal.
  • Carla Lança Área Cientifica de Ortótica, Escola Superior de Tecnologia da Saúde de Lisboa, Instituto Politécnico de Lisboa. Lisboa, Portugal.

DOI:

https://doi.org/10.25758/set.607

Keywords:

Myopia, Contact lenses, Orthokeratology, Multifocal lens, Myopic defocus

Abstract

Introduction Myopia is defined as an excess of positive power in the eye’s optical system, resulting in an image that focuses anteriorly to the retinal plane. It is considered a public health problem; therefore, it becomes relevant to investigate therapies that control its progression. Objectives This systematic review aims to compare the effectiveness of treatments in the reduction of myopia progression in children with soft contact lenses (SCL) and orthokeratology lenses (OKL). Methods Scientific articles were searched on PubMed and ScienceDirect platforms. All articles were screened according to PRISMA guidelines (Preferred Reporting Items for Systematic Reviews and Meta-analyses) and the pre-determined inclusion and exclusion criteria. The treatment efficacy was evaluated by the axial length (AL) variation and/or the refractive error variation measured by cycloplegia (spherical equivalent, SE) between the beginning and the end of the study and between the groups of treatment and controls. Results Thirteen articles were included and divided into two groups. In the OKL group (n=5), eight lenses were studied and their effectiveness in AL progression varied between 0,45mm and 0.09mm. In the SCL group (n=8), 11 lenses were studied and their effectiveness in AL progression ranged from 0.32mm to 0.09mm and in SE progression ranged from 0.14 D to 0.73 D. Conclusion Of all the OKL, the one that showed the greatest efficacy in the progression of AL was Menicon Z Night® lens (OKL): 0.45mm. Of all the SCL, MiSight 1-Day® was the most effective in decreasing both AL and SE progression: 0.32mm and 0.73 D respectively.

Downloads

Download data is not yet available.

References

Williams KM, Bertelsen G, Cumberland P, Wolfram C, Verhoeven VJ, Anastasopoulos E, et al. Increasing prevalence of myopia in Europe and the impact of education. Ophthalmology. 2015;122(7):1489-97.

Wu PC, Huang HM, Yu HJ, Fang PC, Chen CT. Epidemiology of myopia. Asia Pac J Ophthalmol. 2016;5(6):386-93.

Pärssinen O, Kauppinen M. Associations of near work time, watching TV, outdoors time, and parents’ myopia with myopia among school children based on 38‐year‐old historical data. Acta Ophthalmol. 2022;100(2):e430-8.

Holden BA, Fricke TR, Wilson DA, Jong M, Naidoo KS, Sankaridurg P, et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology. 2016;123(5):1036-42.

Lin LL, Shih YF, Hsiao CK, Chen CJ. Prevalence of myopia in Taiwanese schoolchildren: 1983 to 2000. Ann Acad Med Singapore. 2004;33(1):27-33.

Matamoros E, Ingrand P, Pelen F, Bentaleb Y, Weber M, Korobelnik JF, et al. Prevalence of myopia in France: a cross-sectional analysis. Medicine (Baltimore). 2015;94(45):e1976.

Kleinstein RN, Jones LA, Hullett S, kwon S, Lee RJ, Friedman NE, et al. Refractive error and ethnicity in children. Arch Ophthalmol. 2003;121(8):1141-7.

Chua SY, Sabanayagam C, Cheung YB, Chia A, Valenzuela RK, Tan D, et al. Age of onset of myopia predicts risk of high myopia in later childhood in myopic Singapore children. Ophthalmic Physiol Opt. 2016;36(4):388-94.

Ohno-Matsui K, Wu PC, Yamashiro K, Vutipongsatom K, Fang Y, et al. IMI pathologic myopia. Invest Ophthalmol Vis Sci. 2021;62(5):5.

Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editors. Cochrane handbook for systematic reviews of interventions. 2nd ed. Chichester: John Wiley & Sons; 2019.

Santodomingo-Rubido J, Villa-Collar C, Gilmartin B, Gutiérrez-Ortega R, Sugimoto K. Long-term efficacy of orthokeratology contact lens wear in controlling the progression of childhood myopia. Curr Eye Res. 2017;42(5):713-20.

Sankaridurg P, Bakaraju RC, Naduvilath T, Chen X, Weng R, Tilia D, et al. Myopia control with novel central and peripheral plus contact lenses and extended depth of focus contact lenses: 2 year results from a randomised clinical trial. Ophthalmic Physiol Opt. 2019;39(4):294-307.

Lam CS, Tang WC, Tse DY, Tang YY, To CH. Defocus Incorporated Soft Contact (DISC) lens slows myopia progression in Hong Kong Chinese schoolchildren: a 2-year randomised clinical trial. Br J Ophthalmol. 2014;98(1):40-5.

Cheng X, Xu J, Chehab K, Exford J, Brennan N. Soft contact lenses with positive spherical aberration for myopia control. Optom Vis Sci. 2016;93(4):353-66.

Sankaridurg P, Holden B, Smith 3rd E, Naduvilath T, Chen X, de la Jara PL, et al. Decrease in rate of myopia progression with a contact lens designed to reduce relative peripheral hyperopia: one-year results. Invest Ophthalmol Vis Sci. 2011;52(13):9362-7.

Cheung SW, Cho P. Validity of axial length measurements for monitoring myopic progression in orthokeratology. Invest Ophthalmol Vis Sci. 2013;54(3):1613-15.

Jakobsen TM, Møller F. Control of myopia using orthokeratology lenses in Scandinavian children aged 6 to 12 years. Eighteen‐month data from the Danish Randomized Study: Clinical study Of Near‐sightedness - TReatment with Orthokeratology Lenses (CONTROL study). Acta Ophthalmol. 2022;100(2):175-82.

Cho P, Cheung SW. Retardation of myopia in orthokeratology (ROMIO) Study: a 2-year randomized clinical trial. Invest Ophthalmol Vis Sci. 2012;53(11):7077-85.

Chen R, Yu J, Lipson M, CheemaAA, Chen Y, Lian H, et al. Comparison of four different orthokeratology lenses in controlling myopia progression. Cont Lens Anterior Eye. 2020;43(1):78-83.

Chamberlain P, Peixoto-de-Matos SC, Logan NS, Ngo C, Jones D, Young G. A 3-year randomized clinical trial of MiSight lenses for myopia control. Optom Vis Sci. 2019;96(8):556-67.

Walline JJ, Walker MK, Mutti DO, Jones-Jordan LA, Sinnott LT, Giannoni AG, et al. Effect of high add power, medium add power, or single-vision contact lenses on myopia progression in children: the BLINK randomized clinical trial. JAMA. 2020;324(6):571-80.

Ruiz-Pomeda A, Pérez-Sánchez B, Valls I, Prieto-Garrido FL, Gutiérrez-Ortega R, Villa-Collar C. MiSight Assessment Study Spain (MASS): a 2-year randomized clinical trial. Graefes Arch Clin Exp Ophthalmol. 2018;256(5):1011-21.

Garcia-Del Valle AM, Blázquez V, Gros-Otero J, Infante M, Culebras A, Verdejo A, et al. Efficacy and safety of a soft contact lens to control myopia progression. Clin Exp Optom. 2021;104(1):14-21.

Remón L, Pérez-Merino P, Macedo-de-Araújo RJ, Amorim-de-Sousa AI, González-Méijome JM. Bifocal and multifocal contact lenses for presbyopia and myopia control. J Ophthalmol. 2020;2020:8067657.

Liu YM, Xie P. The safety of orthokeratology: a systematic review. Eye Contact Lens. 2016;42(1):35-42.

Published

2023-12-30

Issue

Section

Artigos de Revisão

How to Cite

Myopia control with contact lenses in children: a systematic review. (2023). Saúde & Tecnologia, 29, e607. https://doi.org/10.25758/set.607